Ventyx Biosciences, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Ventyx Biosciences, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Ventyx Biosciences, Inc. Assets for the quarter ending September 30, 2024 was $301M, a 6.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$301M	-$20.6M	-6.4%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$309M	-$39.6M	-11.3%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$332M	-$57.1M	-14.7%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$278M	-$93.7M	-25.2%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$322M	-$98.7M	-23.5%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$349M	+$86.6M	+33%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$389M	+$111M	+40%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$371M	+$79.9M	+27.4%	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$420M	+$272M	+183%	Sep 30, 2022	10-Q	2022-11-04
Q2 2022	$262M			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$278M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$291M	+$46.5M	+19%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$149M			Sep 30, 2021	10-Q	2021-11-18
Q4 2020	$245M			Dec 31, 2020	10-K	2022-03-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.